ARCHIVES

BMS Settles Charges Of Obstructing Generics

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001

NCI Advisory Group, Other Cancer Meetings For Oct., Nov., Future

September 28, 1990

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Senate Committee Blocks Effort To Overturn Organ Systems Changes

December 10, 1982

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975